Cargando…

Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk

OBJECTIVE: To discern presymptomatic changes in brain structure or function using advanced MRI in carriers of mutations predisposing to amyotrophic lateral sclerosis (ALS). METHODS: T1-weighted, diffusion weighted and resting state functional MRI data were acquired at 3 T for 12 asymptomatic mutatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menke, Ricarda A L, Proudfoot, Malcolm, Wuu, Joanne, Andersen, Peter M, Talbot, Kevin, Benatar, Michael, Turner, Martin R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Neurodegeneration
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893149/ https://www.ncbi.nlm.nih.gov/pubmed/26733601 http://dx.doi.org/10.1136/jnnp-2015-311945

Ejemplares similares

Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2016)

Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis
por: Thompson, Alexander G, et al.
Publicado: (2022)

The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey
por: Turner, Martin R, et al.
Publicado: (2015)

Retrotransposons in the development and progression of amyotrophic lateral sclerosis
por: Savage, Abigail L, et al.
Publicado: (2019)

Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
por: Shepheard, Stephanie R, et al.
Publicado: (2021)

Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis
por: Kmetzsch, Virgilio, et al.
Publicado: (2021)

Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights
por: Vucic, Steve, et al.
Publicado: (2013)

Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis
por: Saxon, Jennifer A, et al.
Publicado: (2020)

UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target
por: Willemse, Sean W, et al.
Publicado: (2023)

Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?
por: Kanouchi, Tadashi, et al.
Publicado: (2012)

Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
por: Kassubek, Jan, et al.
Publicado: (2018)

Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis
por: Nitert, Abram D, et al.
Publicado: (2022)

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study
por: Lu, Ching-Hua, et al.
Publicado: (2015)

Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias
por: Mehta, Puja R, et al.
Publicado: (2019)

Primary lateral sclerosis: consensus diagnostic criteria
por: Turner, Martin R, et al.
Publicado: (2020)

Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis
por: Wilson, Katherine M, et al.
Publicado: (2022)

Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal
por: Benatar, Michael, et al.
Publicado: (2022)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2020)

Altered cortical beta‐band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis
por: Proudfoot, Malcolm, et al.
Publicado: (2016)

Genetic screening in sporadic ALS and FTD
por: Turner, Martin R, et al.
Publicado: (2017)

Motor cortex functional connectivity is associated with underlying neurochemistry in ALS
por: Dey, Avyarthana, et al.
Publicado: (2023)

Neuronal network disintegration: common pathways linking neurodegenerative diseases
por: Ahmed, Rebekah M, et al.
Publicado: (2016)

Genotype-associated cerebellar profiles in ALS: focal cerebellar pathology and cerebro-cerebellar connectivity alterations
por: Bede, Peter, et al.
Publicado: (2021)

Medial temporal lobe epilepsy is associated with neuronal fibre loss and paradoxical increase in structural connectivity of limbic structures
por: Bonilha, Leonardo, et al.
Publicado: (2012)

Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains
por: Keogh, Michael J, et al.
Publicado: (2018)

Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
por: Benatar, Michael, et al.
Publicado: (2021)

Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis
por: Bäumer, Dirk, et al.
Publicado: (2014)

Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes
por: Forsberg, Karin, et al.
Publicado: (2019)

Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity
por: Benatar, Michael, et al.
Publicado: (2022)

Relative preservation of triceps over biceps strength in upper limb-onset ALS: the ‘split elbow’
por: Khalaf, Roaya, et al.
Publicado: (2019)

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
por: Menke, Ricarda A. L., et al.
Publicado: (2016)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
por: Menke, R.A.L., et al.
Publicado: (2017)

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2015)

Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis
por: Proudfoot, Malcolm, et al.
Publicado: (2019)

Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans
por: Maccecchini, Maria L, et al.
Publicado: (2012)

An algorithmic approach to structural imaging in dementia
por: Harper, Lorna, et al.
Publicado: (2014)

Validation of the new consensus criteria for the diagnosis of corticobasal degeneration
por: Alexander, S K, et al.
Publicado: (2014)

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
por: Magdalinou, Nadia, et al.
Publicado: (2014)

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
por: Berge, Guro, et al.
Publicado: (2014)

Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records
por: Evans, Stephen JW, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dq7eub3cqdduh7rhpugevnh382